Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 353

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome

Dokras, Anuja, Bochner, Melinda, Hollinrake, Elizabeth, Markham, Sanford, VanVoorhis, Bradley, Jagasia, Dinesh H.·2005·Obstetrics & Gynecology

Abstract

OBJECTIVE: Women with polycystic ovary syndrome (PCOS) are at an increased risk for insulin resistance and hyperlipidemia. Metabolic syndrome is a cluster of risk factors that confers an increased risk for cardiovascular disease. The objectives of this study were to compare the prevalence of metabolic syndrome in women with PCOS and controls and to identify the role of androgens or insulin resistance in the development of metabolic syndrome. METHODS: Women with PCOS (n = 129) and women with regular menses and no hirsutism seen for an annual examination (n = 177) were studied. RESULTS: The age-adjusted prevalence of metabolic syndrome was higher in women with PCOS (47.3%, 95% confidence interval 35.3-56.9%) compared with controls (4.3%, 95% confidence interval 1.9-7.6%, P < .001). Compared by age group, the risk of metabolic syndrome in women with PCOS was higher for all groups (P < .001). There were no significant differences in serum androgen levels between women with PCOS with or without metabolic syndrome. In contrast, all markers of insulin resistance were abnormal in women with PCOS with metabolic syndrome compared with those without metabolic syndrome (P < .001). We found serum triglyceride/high density lipoprotein cholesterol (TG/HDL-C) ratio correlated with insulin resistance in this population (P < .001). Serum TG/HDL-C > 3.2 has a high sensitivity and specificity for the detection of metabolic syndrome in women with PCOS. CONCLUSION: Women with PCOS have a 11-fold increase in the prevalence of metabolic syndrome compared with age-matched controls. The risk of metabolic syndrome is high even at a young age, highlighting the importance of early and regular screening. The TG/HDL-C ratio may serve as a screening tool and needs to be prospectively validated in this group. LEVEL OF EVIDENCE: II-2.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.aog.0000167408.30893.6b

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 353

Metadata

Authors
Dokras, A., Bochner, M., Hollinrake, E., Markham, S., VanVoorhis, B., & Jagasia, D. H.
Venue
Obstetrics & Gynecology
Published
2005-07
Volume
106
Issue
1
Pages
131-137
ISSN
0029-7844 (ISSN-L)
OpenAlex
W2110925381
Cited by
353
References
29
FWCI
20.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome. https://app.cochat.ai/papers/10.1097/01.aog.0000167408.30893.6b
The paper
Dokras, A., Bochner, M., Hollinrake, E., Markham, S., VanVoorhis, B., & Jagasia, D. H. (2005). Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome. Obstetrics & Gynecology. https://doi.org/10.1097/01.aog.0000167408.30893.6b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.